latest news releases from the newsroom
Eagle Bulk Shipping Inc.
Eagle Bulk Shipping Inc. to Issue First Quarter 2008 Results and Hold Investor Conference Call
NEW YORK, April 28, 2008 (PRIME NEWSWIRE) -- Eagle Bulk Shipping Inc. (Nasdaq:EGLE) will report its financial results for the first quarter ended March 31, 2008, after the close of stock market trading on Tuesday, May 6th. Members of Eagle Bulk's senior management team will host a teleconference and webcast at 8:30 a.m. ET on Wednesday, May 7th, to discuss the results.
NVE Schedules Conference Call On Fourth Quarter and Fiscal Year Results
EDEN PRAIRIE, Minn., April 28, 2008 (PRIME NEWSWIRE) -- NVE Corporation (Nasdaq:NVEC) announced that it plans to release its financial results for the quarter and fiscal year ended March 31, 2008 on Wednesday, May 7, 2008 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time.
Entropic Communications Reports First Quarter Results
SAN DIEGO, April 28, 2008 (PRIME NEWSWIRE) -- Entropic Communications, Inc. (Nasdaq:ENTR), a leading provider of silicon solutions to enable connected home entertainment, today reported its first quarter results for the period ended March 31, 2008. Entropic reported first quarter net revenues of $42.0 million, an increase of 4.5% compared with $40.2 million in the fourth quarter of 2007 and 110% higher than in the first quarter of 2007. The revenues in the first quarter of 2008 included revenues related to the acquisition of RF Magic, compared with the first quarter of 2007 which was prior to the acquisition.
Baxano Surgical, Inc.
TranS1 Inc. Receives FDA 510(k) Clearance for the AxiaLIF 2L, Two Level Percutaneous Lumbar Fusion System
WILMINGTON, N.C., April 28, 2008 (PRIME NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease affecting the lower lumbar region of the spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AxiaLIF 2L(tm), two level percutaneous lumbar fusion system, in the United States. The AxiaLIF 2L(tm) is designed to treat degenerative disc disease at both the L5-S1 and L4-L5 lumbar discs through a single, one and a half inch incision.
Momenta Pharmaceuticals to Present At Deutsche Bank 33rd Annual Health Care Conference
CAMBRIDGE, Mass., April 28, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Craig Wheeler, Chief Executive Officer, will deliver a corporate presentation at the Deutsche Bank 33rd Annual Health Care Conference on Monday, May 5th at 3:20 p.m. ET. The conference will be held at The InterContinental Boston in Boston, MA.
Rand Capital Corporation
Rand Capital Announces First Quarter Results and Election of Directors and Officers
BUFFALO, N.Y., April 28, 2008 (PRIME NEWSWIRE) -- Rand Capital Corporation (Nasdaq:RAND) ("Rand"), a business development company (BDC) that provides capital and managerial expertise for small to medium-sized private companies, announced its financial results for the first quarter ended March 31, 2008. Rand's net asset value as of March 31, 2008 was $3.45 per share and Rand's total investment portfolio was valued at $26.4 million, which exceeds its cost basis of $13.4 million, reflecting $13.0 million in net unrealized appreciation.